Clinical Trial Site

Santo Domingo

0 studies enrolling now · 1 studies all time

What they study most

Human Immunodeficiency Virus (HIV)-1 Infection

Studies at this site

• Open-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014A — Completed